Radiation Shielding of a 230 MeV Proton Cyclotron For Cancer Therapy

Similar documents
Radiation protection issues in proton therapy

NEUTRON H*(10) INSIDE A PROTON THERAPY FACILITY: COMPARISON BETWEEN MONTE CARLO SIMULATIONS AND WENDI-2 MEASUREMENTS

Towards efficient and accurate particle transport simulation in medical applications

Secondary Neutron Dose Measurement for Proton Line Scanning Therapy

Progress in Nuclear Science and Technology, Volume 6,

Units S H I E L D I N H = D Q. H: Dose equivalent (Sv) D: Dose (Gy) Q: Quality Factor. 1Sv = 1 J/Kg. 1Gy = 1 J/Kg

Secondary Particles Produced by Hadron Therapy

Shielding Design Considerations for Proton Therapy Facilities

Secondary Radiation and Shielding Design for Particle Therapy Facilities

Overview and Status of the Austrian Particle Therapy Facility MedAustron. Peter Urschütz

Monte Carlo Simulation concerning Particle Therapy

Radiation safety of the Danish Center for Proton Therapy (DCPT) Lars Hjorth Præstegaard Dept. of Medical Physics, Aarhus University Hospital

City University of Hong Kong

Accelerators for Hadrontherapy -- Present & Future --

COMPARISON OF COMPUTER CODES APPLICABILITY IN SHIELDING DESIGN FOR HADRON THERAPY FACILITIES *

Development of beam delivery systems for proton (ion) therapy

Practical Radiation Control at KEK

A study on the cost of concrete shielding in a standard radiotherapy facility room

Radiation Shielding. PTCOG 57 Cincinnati, USA (2018)

Optimization of hadron therapy proton beam using Monte Carlo code on GPU

SLAC-PUB Submitted to Radiation Protection and Dosimetry. Work supported by Department of Energy contract DE-AC02-76SF00515

FLUKA simulations of selected topics regarding proton pencil beam scanning

Evaluate Shielding Design of the Brachytherapy Unit by Using Monte Carlo Simulation Code

1. RADIOACTIVITY AND RADIATION PROTECTION

Estimate of Photonuclear Reaction in a Medical Linear Accelerator Using a Water-Equivalent Phantom

Measurement of induced radioactivity in air and water for medical accelerators

Calculations of Photoneutrons from Varian Clinac Accelerators and Their Transmissions in Materials*

Estimation of Radioactivity and Residual Gamma-ray Dose around a Collimator at 3-GeV Proton Synchrotron Ring of J-PARC Facility

THE mono-energetic hadron beam such as heavy-ions or

Shielding verification and neutron dose evaluation of the Mevion S250 proton therapy unit

Neutron source strength measurements for Varian, Siemens, Elekta, and General Electric linear accelerators

Accelerator Facility Accident Report

Best Particle Therapy, Inc. is Developing a Highly Revolutionary New Treatment for Cancer Therapy

ICTP-IAEA Joint Workshop on Nuclear Data for Science and Technology: Medical Applications. 30 September - 4 October, 2013

Laser-Accelerated protons for radiation therapy

Activation Products in Proton Therapy

Nuclear medicine and Radiation technologies

Volume 1 No. 4, October 2011 ISSN International Journal of Science and Technology IJST Journal. All rights reserved

Neutron Spectroscopy in Proton Therapy

Shielding calculations for the design of new Beamlines at ALBA Synchrotron

Radiation Safety Considerations for the TPS Accelerators

Measurements of Radiation Doses Induced by High Intensity Laser between and W/cm 2 onto Solid Targets at LCLS MEC Instrument

Calibration of the GNU and HSREM neutron survey instruments

Introduction to Medical Physics

Shielding Design for the Imaging and Medical Beamline at the Australian Synchrotron

Radiation shielding for undulator beamline in Indus-2 synchrotron radiation source

European Organisation for Nuclear Research European Laboratory for Particle Physics

Beam Optics for a Scanned Proton Beam at Loma Linda University Medical Center

Neutron field analysis for a proton therapy installation

Outline. Physics of Charge Particle Motion. Physics of Charge Particle Motion 7/31/2014. Proton Therapy I: Basic Proton Therapy

ACCELERATORS AND MEDICAL PHYSICS 3

Biological Dose Calculations for Particle Therapy in FLUKA

APPLIED RADIATION PHYSICS

8/3/2016. Chia-Ho, Hua St. Jude Children's Research Hospital. Kevin Teo The Hospital of the University of Pennsylvania

Current and Recent ICRU Activities in Radiation Protection Dosimetry and Measurements

arxiv: v2 [physics.med-ph] 29 May 2015

Peter J. Biggs Ph.D. Massachusetts General Hospital Harvard Medical School Boston, MA 02114

RADIOLOGICAL IMPACT OF THE TRIGAACCELERATOR-DRIVEN EXPERIMENT (TRADE)

Radiation Shielding of Extraction Absorbers for a Fermilab Photoinjector

Production of X-rays. Radiation Safety Training for Analytical X-Ray Devices Module 9

Doing the right thing, doing it right

Chapter 10 Acceptance Tests and Commissioning Measurements

A NEW HIGH PERFORMANCE ALGORITHM FOR MODERN TREATMENT PLANNING SYSTEMS

Dosimetric Quantities and Neutron Spectra Outside the Shielding of Electron Accelerators

Shielding Aspects of Accelerators, Targets and Irradiation Facilities SATIF 10 ISBN (print) OECD 2010 CORRIGENDUM

THE ACTIVE PERSONNEL DOSIMETER - APFEL ENTERPRISES SUPERHEATED DROP DETECTOR*

neutron building Project Title: Moderator design of RANS2 and investigating of radiation equivalent dose for Name: Sheng Wang

Radiation Safety In-Service House-Keeping and Security Departments. Petrone Associates LLC Specialists in Applied Medical Physics

M. Martišíková 1,3, C. Granja 2, J. Jakůbek 2, B. Hartmann 1,3, K. Gwosch 1, P. Soukup 2 and O. Jäkel 1,3,5

Introduction to Medical Physics

The volume effect of detectors in the dosimetry of small fields used in IMRT

S. Agosteo 1,A. Porta 1, L. Ulrici 2

Activation of Air and Concrete in Medical Isotope Production Cyclotron Facilities

Evaluation and Measurements of Radioactive Air Emission and Off-Site Doses at SLAC

Chapter 8 Electron Beams: Physical and Clinical Aspects

Estimation of neutron and gamma radiation doses inside the concrete shield wall for 10 and 15 MV medical linear accelerators

A Measuring System with Recombination Chamber for Photoneutron Dosimetry at Medical Linear Accelerators

Isotope Production for Nuclear Medicine

DESIGN OF A TREATMENT ROOM FOR AN 18-MV LINAC

MONTE CARLO SIMULATION FOR EVALUATION OF DOSE DISTRIBUTION IN PROTON THERAPY *

Radiation Friend or Foe? Saturday Physics for Everyone 7 Oct 2017 Kevin Pitts

Proton and neutron radiation facilities in the PS East hall at CERN

Fast-Neutron Production via Break-Up of Deuterons and Fast-Neutron Dosimetry

Radiation exposure of personnel during IORT: radiation protection aspects.

Jeancarlo Torres, CHP. Naval Surface Warfare Center Carderock Division

Shielding design for a laser-accelerated proton therapy system

Experimental Microdosimetry in High Energy Radiation Fields

M d e i di l ca A pplilli t ca i ttions o f P arti ttic ti l P e h Physics Saverio Braccini INSEL

NEUTRON EXPOSURE FROM ELECTROM LINEAR ACCELERATORS AND A PROTON ACCELERATOR: MEASUREMENTS AND SIMULATIONS

Lab #13: MEASUREMENT OF RADIATION DOSES

Hospital Cyclotrons: Radiation Safety Aspects. Matthew Griffiths

Using Prompt gamma ray emission to address uncertainties in proton therapy

Simulation Modeling in Dosimetry

CRaTER Pre-Ship Review (PSR) Instrument Calibration Science Requirements Compliance

ELECTRON INTERACTIONS

Physics. Sunday, March 4, :30 a.m. 10:00 a.m.

Dielectric Wall Accelerator (DWA) and Distal Edge Tracking Proton Delivery System Rock Mackie Professor Dept of Medical Physics UW Madison Co-Founder

Towards Proton Computed Tomography

Neutron Spectrum Measurement in a Medical Cyclotron

Current issues of radiation safety regulation for accelerator facilities in Japan

Transcription:

Radiation Shielding of a 230 MeV Proton Cyclotron For Cancer Therapy BHASKAR MUKHERJEE Joint DESY and University of Hamburg Accelerator Physics Seminar 27 August 2009

WPE is located within the Campus of Universitätsklinikum tsklinikum Essen Surrounded by Kindergarten Nurses Hostel Guest House Institute Complex (Universität Duisburg-Essen) Mensa Strahlentherapie/Tumorforschung Tumorforschung- UK Essen Gurga National Park Hence, an Adequate Radiological Safety becomes Mandatory 2

Principle of Proton Therapy Highly localised energy delivery of protons in the tumour surrounded by healthy tissue. Large dose sparing in healthy tissue region. On the other hand, conventional high- energy X-rays X delivers the major share of radiation dose outside the tumour volume. Example: Radiotherapy of Brain Stem Tumour (A.( J. Lomax et al. Radio- therapy and Oncology 51(1999) 257-271 271) Conventional Photons: No dose sparing at brain stem (red zone) Intensity Modulated Photons (IMRT): 50-60% dose sparing (yellow zone) Proton Therapy: 0-30% 0 dose sparing (grey zone) 3

Architectural Concept of the WPE Facility 230 MeV Proton Cyclotron, Diagnostic & Imaging Facilities (CT/MRI) and Treatment (Gantry) rooms are located underground (-1( 1 level). Patient reception, Employees offices, Workshops and Health Physics Laboratory are located at Ground Floor (0 level). IT Station and Storage Rooms are located at First Floor (+1 level). l). Climate & Ventilation Facilities are located at Second Floor (+2 level). 4

The Skeletal Perspective of the WPE Cyclotron and Tumour Irradiation Facilities Overall Length of the Facility: approx. 120 m Maximum Diameter of the Rotating Gantry: 7 m Weight of the Rotating Gantry: approx. 100 Tonne Maximum Permissible Deformation: 0.5 mm 5

The Isocentric Gantry One of the three Isocentric Gantries located at WPE Treatment Rooms. A computer simulated drawing showing the Nozzle and Robotic Patient Positioning Set up. 6

Motivation and Goal of this Talk Validation of the Shielding Efficacy of the WPE Treatment Rooms housing Proton Irradiation Gantries. In this Shielding Calculation we have used the well proven Deterministic Moyer Model The Source Terms for this Shielding Calculation were derived from Experiments carried out under Clinical Conditions at PSI as well as FLUKA Simulations Results to be confirmed by 55 and 46 of German StrSchV 7

Introduction Footprint of the WPE Treatment Rooms and 230 MeV Proton Cyclotron All four Treatment Rooms have basically the same physical dimensions Therapeutic Proton beam delivered to one treatment room at a time We have considered Treatment Room #3 for this Shielding Calculation Neutron Source (circle( circle) ) and Dose Calculation Points (rectangle( rectangle) ) are indicated 8

Neutron Source Term Neutron Dose Equivalent at Target => Shielding Calculation Kernel Proton Irradiation Experiment at under Clinical Condition (Collaboration with PSI Switzerland) 177 MeV Pencil Beam Stopped in Water Target Neutron Dose Equivalent (DE) evaluated at different angles using a LB 6411 Neutron Rem Counter Neutron DE at 1m measured at 0 o, 30 o, 90 o and 120 o are presented below: (a) standard LB 6411 Rem Counter, (b) corrected (x 1.4) corresponding to an extended range Rem Counter, (c) Extrapolated to 180 o (reverse direction) Source Terms calculated to be: 90 o H 0 = 7.25 msv.h -1.nA (Lateral Direction) na -1 180 o H 0 = 6.24 msv.h -1.nA (Reverse Direction) na -1 9

Notes on High-Energy Neutron Rem Counters At higher (E n > 10 MeV) neutron energies Standard Rem Counters (i.e. LB 6411 or NM 500) under response relative to Extended Range Rem Counter ( Wendi-2). At WPE high energy neutrons prevail. Hence, for Radiation Measurement ement and Dosimetry the usage of Extended Range Rem Counter (Wendi-2) becomes mandatory. 10

FLUKA Simulation of Neutron Source Term Irradiation Set up Ep = 230 MeV FLUKA Model FLUKA Simulated Secondary Neutron Spectra (Source Term) 11

The Moyer Model for Shielding Calculation Following Criteria to be fulfilled Sufficiently thick shielding ( d > 1m) Point size radiation source (neutron producing TargetT arget) Large Target to Reference point distance ( r >> d) Valid only for Neutron Shielding Neutron Dose Equivalent at Reference Point is given as (1) Lateral Direction H = 90o H 0 (r/sin sinφ) -2 exp(-d/ d/λsinφ) or, H/ 90o H 0 = (r/sin sinφ) -2 exp(-d/ d/λsinφ) (2) Reverse Direction H = 180o H 0 (r) -2 exp(-d/ d/λ) or, H/ 180o H 0 = (r/) -2 exp(-d/ d/λ) H/ 90o H 0 and H/ 180o H 0 are the Neutron Transmission Factors (Shielding Efficacy) λ = Neutron Attenuation Length in Concrete (SLAC PUB 130339 12

Shielding Calculation (i) Footprint of Treatment Room #3 Path Lengths r/ r/sinφ and d/ d/sinφ Shielding Efficacy at reference points A, B, C, D and E d given as: H/ 90o H 0 = (r/sin sinφ) -2 exp(-d/ d/λsinφ) ) ; Results are presented in TABLE 1 Neutrons transmitted along the 3 legged maze (Em( Em) heve been calculated (next section) 13

Shielding Calculation (ii) Neutron Attenuation through the Maze Dimensions of the 2.6 m high maze. E m and S m represent the reference point and virtual radiation source respectively. 1st Leg: H 1 /H 0 = 0.98 exp(-0.80r 1 / A) + 0.2 2nd Leg: H 2 /H 0 = 0.74 exp(-10r 2 / A) + 0.21 exp(-1.6r 2 / A) + 0.05 exp(-0.54r 2 / A) 3rd Leg: H 3 /H 0 = 0.81 exp(-3.8r 3 / A) + 0.19 exp(-0.70r3/ 0.70r3/ A) r 1, r 2 and r 3 represent the length of maze legs and A the cross section area. Results are presented in TABLE 2 14

Shielding Calculation (iii) Neutron Dose Equivalent at Roof Vertical Cross Section of Treatment Room #3 Shielding Efficacy at reference point R (opposite to Isocenter) ) is given as H/ 180o H 0 = (r) -2 exp(-d/ d/λ) ) ; r = 11.17m and d = 2.44m Results are presented in TABLE 1 15

Results Table 1: Neutron path lengths r/ r/sinφ,, effective shield thickness d/ d/sinφ and neutron transmission factor H/H 0 evaluated using Moyer Model. Neutron trans- mission factor at maze entrance is composed of direct component E d and transmitted (maze) component E m (s. Table 2). Table 2: Showing the reference points along the maze, length of maze leg and the corresponding neutron transmission factor. 16

Worst Case Exposure Scenario A 10 na pencil proton beam (E P = 177 MeV) completely stopped in a water target 46 of StrSchV: : Permissible Dose to Public is 1.0 msv in 2000 hours per Year. This corresponds to a Dose Equivalent rate of H StrSchV = 0.5 µsv.h -1 Transmitted neutron DE rate (shielding efficacy) is compared to permissible DE rate according to 46 of StrSchV (TABLE 3). 3 Table 3: Transmitted neutron Dose Equivalent Rate (worst case scenario) at selected reference points (Treatment Room #3) evaluated using Moyer Model.. Results were compared to the permissible Neutron DE to public according to 46 of German StrSchV (H/ StrSchV ) and presented in Column 4. (H/H StrSchV 17

Conclusions and Recommendations We have validated the existing radiation shielding of the WPE Treatment Rooms for 177 MeV protons using Deterministic Moyer Model. Highly conservative operational scenarios have been taken into account. a These calculations confirm the adequacy of the existing radiation shielding, applicable to locations outside the WPE treatment rooms and roof. FLUKA simulations have been carried out for shielding calculation n at the highest proton energy (230 MeV). Experiments will be carried out at clinical environment at our facility f to confirm the FLUKA results shortly. We have developed a composite material of high attenuation capability for fast neutron shielding at future particle therapy facilities. Recent activities of our group are highlighted in the APPENDIX 18

APPENDIX European Cyclotron Progress Meeting (ECPM XXXVII) Groningen,, The Netherlands, 28-31 October 2009 Accepted Oral Presentations B. Mukherjee, J. Farr, C. Bäumer and R. Hentschel. Radiation Shielding Design for Proton Therapy Treatment Rooms. B. Mukherjee, R. Hentschel,, C. Bäumer and J. Farr. Monte Carlo Simulation of a Novel Composite Shielding for High-Energy Neutrons produced by Proton Therapy Cyclotrons. THANK YOU FOR YOUR KIND ATTENTION 19